Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock

$22.97

0.44% day before yesterday

NYSE, Dec 27, 10:00 pm CET

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$22.97

-14.46 38.63% 5Y

NYSE, Closing price Fri, Dec 27 2024

+0.10 0.44%

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$13.48b
Enterprise Value	$25.76b
P/E (TTM) P/E ratio	18.86
EV/FCF (TTM) EV/FCF	15.16
EV/Sales (TTM) EV/Sales	1.24
P/S ratio (TTM) P/S ratio	0.65
P/B ratio (TTM) P/B ratio	0.89
Dividend yield	2.80%
Last dividend (FY24)	$0.64
Revenue growth (TTM) Revenue growth	0.42%
Revenue (TTM) Revenue	$20.85b
EBIT (operating result TTM) EBIT	$1.77b
Free Cash Flow (TTM) Free Cash Flow	$1.70b
Cash position	$1.53b
EPS (TTM) EPS	$1.22
P/E forward	18.39
P/S forward	0.66
EV/Sales forward	1.26
Short interest	0.20%

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Get Started for Free Today

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

7x Buy

33%

9x Hold

43%

5x Sell

24%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy

33%

Hold

43%

Sell

24%

Analyst Estimates with Stock Price Targets

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	20,852 20,852	0% 0% 100%
- Direct Costs	15,612 15,612	1% 1% 75%
Gross Profit	5,240 5,240	0% 0% 25%
- Selling and Administrative Expenses	1,579 1,579	2% 2% 8%
- Research and Development Expense	216 216	11% 11% 1%
EBITDA	3,445 3,445	0% 0% 17%
- Depreciation and Amortization	1,676 1,676	9% 9% 8%
EBIT (Operating Income) EBIT	1,770 1,770	10% 10% 8%
Net Profit	715 715	49% 49% 3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral

PRNewsWire

●

6 days ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Ranking puts Fresenius Medical Care among the best-in-class sustainability performers in the world and Europe The company recorded progress towards its sustainability targets Sustainability is one of the essential drivers for future BAD HOMBURG, Germany , Dec. 23, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal ...

Neutral

PRNewsWire

●

9 days ago

Fresenius Medical Care returns to Dax 40 Index

BAD HOMBURG, Germany , Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of the German Stock Index, the DAX 40, as of December 27, 2024. The index represents the performance of the 40 largest publicly traded companies listed on the Frankfurt Stock Exchange and accounts for...

Neutral

Seeking Alpha

●

about 2 months ago

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Fresenius Medical Care AG (NYSE:FMS ) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer and Chair Martin Fischer - Chief Financial Officer Conference Call Participants Richard Felton - Goldman Sachs Victoria Lambert - Berenberg Robert Davies - Morgan Stanley Hugo Solvet - BNP Paribas Ol...

More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office	Germany
CEO	Helen Giza
Employees	119,845
Founded	1996
Website	www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now